BRASIL PHARMA S.A.

Publicly-held Company

National Corporate Taxpayers Register of the Ministry of Finance (CNPJ/MF) No.
11.395.624/0001-71
State Registration Number NIRE 35.300.374.797

NOTICE OF MATERIAL FACT Brasil Pharma appoints new CEO São Paulo, March 10, 2014 - Brasil Pharma SA (BM&FBOVESPA: BPHA3) hereby announces that its Board of Directors has unanimously appointed José Ricardo Mendes da Silva as its new Chief Executive Officer (CEO).

After participating in a primordial stage of formation and structuring of Brasil Pharma, always driven by its dream of being the best drugstore chain in Brazil, André Soares de Sá ends its cycle ahead of the command of the Company to be exclusively dedicated to its Board of Directors.
For more than four years as CEO, André led the audacious acquisition process of key regional operations, making Brasil Pharma one of the largest consolidators in the Brazilian pharmaceutical retail and one of the national industry leaders. André also captained the process of the Company' IPO with its listing on the Novo Mercado segment of the BM&FBOVESPA.
José Ricardo assumes the new position in order to promote sustainable growth of the
Company, ensuring the profitability of the noteworthy investments made in its conception. With
35 years of career in large companies, José Ricardo has proven leadership and organizational management skills.
José Ricardo joined Brasil Pharma in December 2013 as Vice President of Strategy and Finance. Before joining Brasil Pharma, José Ricardo worked for 11 years at Aché, one of the leading industries in the Brazilian pharmaceutical market, where he held the position of Chief Executive Officer from 2006 to 2013. During the period, in addition to leading the successful integration of recent acquisitions and a new round of product launches, he promoted significant growth in the company's profitability, which achieved investment grade ratings. From 1996 to
2000, he served as Human Resources Officer, Chief Financial Officer and Investor Relations
Officer at Elevadores Atlas Schindler S/A.
Brasil Pharma welcomes José Ricardo and thanks André Sá for the years dedicated to the creation and structuring of the Company.

New Structure: Apart from CEO, José Ricardo assumes the post of Investor Relations Officer, a position hitherto occupied by Renato Lobo, who continues its work as Director of Operations.

More details concerning the above mentioned will be given during 4Q13 Conference Call.
For more information please contact the Investor Relations department of Brasil Pharma
(www.brasilpharma.com.br/ri| ri@brph.com.br | +55 (11) 2117-5299).

JOSÉ RICARDO MENDES DA SILVA

Chief Executive Officer and Investor Relations Officer

distributed by